Free tool
FAERS Monitor: Desvenlafaxine
Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 204150 or its brand name (Desvenlafaxine, Desvenlafaxine). Reports on generic versions are filed under their own applications.
Reports
5,261
Serious
3,264
62% of reports
Hospitalization
1,369
Death reported
457
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective718
- off label use369
- nausea351
- toxicity to various agents304
- headache299
- anxiety297
- fatigue284
- depression245
- dizziness234
- completed suicide214
- drug interaction208
- overdose205
- pain186
- insomnia178
- suicidal ideation176
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2008 | 4 |
| 2009 | 11 |
| 2010 | 43 |
| 2011 | 28 |
| 2012 | 68 |
| 2013 | 61 |
| 2014 | 36 |
| 2015 | 118 |
| 2016 | 82 |
| 2017 | 297 |
| 2018 | 249 |
| 2019 | 372 |
| 2020 | 472 |
| 2021 | 492 |
| 2022 | 674 |
| 2023 | 630 |
| 2024 | 578 |
| 2025 | 560 |
| 2026 | 486 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,898 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| completed suicideSignal | 214 | 10.3 | 9.0 | 1,788 |
| drug interactionSignal | 208 | 5.2 | 4.6 | 715 |
| depressionSignal | 245 | 4.3 | 3.8 | 625 |
| anxietySignal | 297 | 4.2 | 3.7 | 723 |
| overdoseSignal | 205 | 3.8 | 3.3 | 424 |
| insomniaSignal | 178 | 2.7 | 2.3 | 187 |
| drug ineffectiveSignal | 718 | 2.2 | 2.0 | 487 |
| headache | 299 | 1.9 | 1.7 | 132 |
| dizziness | 234 | 1.9 | 1.7 | 97 |
| nausea | 351 | 1.8 | 1.6 | 122 |
| off label use | 369 | 1.7 | 1.5 | 106 |
| fatigue | 284 | 1.5 | 1.3 | 42 |
| pain | 186 | 1.2 | 1.1 | 7 |
| toxicity to various agents | 304 | 0.0 | 0.0 | 1,212,302 |
| suicidal ideation | 176 | 0.0 | 0.0 | 700,173 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.